Document is current
Any future updates will be listed below
-
Authors
Lin, Po-Han
Chen, Shin-Cheh
Tseng, Ling-Ming
Chang, King-Jen
Huang, Ai-Chu
Cheng, Kuo-Chih
Yang, Karen
Wu, Hui-Chen
Chao, Tsu-Yi
Chang, Yuan-Ching
Lin, Peng-Chan
Kuo, Wen-Hung
Kuo, Wen-Lin
Lin, Ching-Hung
Chen, Huo-Mu
Yeh, Dah-Cherng
Liu, Liang-Chih
Liu, Chun-Yu
Wang, Ming-Yang
Lo, Chiao
Lu, Yen-Shen
Huang, Chiun-Sheng https://orcid.org/0000-0002-6557-211X
-
Funding
Funding for this research was provided by:
Ministry of Science and Technology, Taiwan (MOST 104-2314-B-002-106-MY3, MOST 109WFA0111726)
National Taiwan University Hospital (NTUH. 107-004068)
- License Information
-
More Information
Article History
Received: 2 March 2021
Accepted: 12 November 2021
First Online: 3 February 2022
Declarations
:
: All the authors declare that they have no conflict of interest.
: <i>BRCA</i> mutation patients were collected from two studies, which were approved by the Medical Ethics Committee of the National Taiwan University Hospital (201308077RINA and 201706090RINA). Ninety patients received gene diagnosis at National Taiwan University Hospital. Although other patients were diagnosed at other hospitals, most of the <i>BRCA</i> mutation carriers were refereed to genetic clinic of the National Taiwan University Hospital for genetic counseling so we could collect their data.
: In this study, all procedures were performed in accordance with the Declaration of Helsinki.
